April 29, 2017 11:43 AM ET

Life Sciences Tools and Services

Company Overview of STEMCELL Technologies Canada Inc.

Company Overview

STEMCELL Technologies Canada Inc. develops cell culture media, cell separation systems, instruments, and other reagents to support research in the fields of immunology, hematology, neuroscience, mesenchymal stem cell, stem cell, and epithelial cell biology. It offers antibodies, buffers and solutions, cell culture media and supplements, cell dyes and detection assay kits, cell isolation products, cell storage media, cultureware and general supplies, cytokines, density gradient media, ELISAs, instruments and software, laboratory equipment, matrices and substrates, primary and cultured cells, small molecules, standardization tools, and tissue and cell culture dissociation reagents. The company...

570 West Seventh Avenue

Suite 400

Vancouver, BC V5Z 1B3

Canada

Founded in 1993

Phone:

604-877-0713

Fax:

604-877-0704

Key Executives for STEMCELL Technologies Canada Inc.

Chief Executive Officer and President
Compensation as of Fiscal Year 2016.

STEMCELL Technologies Canada Inc. Key Developments

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies

Cellular Dynamics International announced that, it has signed a distribution agreement with STEMCELL Technologies. Under the terms of the agreement, STEMCELL Technologies will distribute CDI’s iCell® catalog of products in North America, Europe, and Singapore, with other countries under consideration. CDI’s iCell products are differentiated human induced pluripotent stem cell (iPSC)-derived cells, which include cardiomyocytes, hepatocytes, and others, totaling up to 12 cell types.

STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK

STEMCELL Technologies UK has recently celebrated the grand opening of their Cambridge-based facility. Founded by Dr. Allen Eaves, STEMCELL provides specialized reagents and tools that support research on cancer and other diseases, as well as cell therapy and regenerative medicine globally. Cambridge is a leading global hub for stem cell research. This, combined with its proximity to STEMCELL’s customers in the UK and Europe, makes the location a natural choice for continued investment by the company. STEMCELL recently took possession of an 18,000 square foot building located in the Cambridge Research Park. STEMCELL has now consolidated existing UK staff into the facility, which at full capacity will house a substantial Research and Development group, as well as Sales, Marketing and other support staff. A major focus of the new facility will be a Education and Teaching Lab. STEMCELL offers several standard and customized training courses and workshops, which are currently hosted within collaborating academic lab facilities. The multi-day, interactive courses are designed to help researchers develop expertise in protocols and techniques supported by STEMCELL’s products. Several of these world-class courses will soon be offered in the new Cambridge facility, making them more accessible to researchers in the UK and Europe.

STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology

STEMCELL Technologies Inc. announced that has signed an exclusive license agreement with Cincinnati Children’s Hospital Medical Center to commercialize its fundamental technology for generating gastrointestinal organoids from pluripotent stem cells (PSCs). This agreement grants STEMCELL a license to novel methods for generating organoid models and to develop cell culture media and tools that would enable scientists to create organoids from PSCs in their own laboratories. The technology licensed from Cincinnati Children’s describes methods for generating gastrointestinal organoids, including intestinal and stomach, from human PSCs.

Similar Private Companies By Industry

Company Name Region
Acclaim Pharma Research, Inc. Americas
Allphase Clinical Research Services Inc. Americas
Altasciences Company Inc. Americas
Apex Laboratories International, Inc. Americas
Applitox Bio Pharma, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact STEMCELL Technologies Canada Inc., please visit www.stemcell.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.